SKILLMAN, N.J., March 3, 2011 /PRNewswire/ — ConvaTec
Healthcare, a world-leading developer, manufacturer and marketer of
innovative medical technologies for community and hospital care,
today announced that, recognizing favorable conditions in the
credit markets, it is exploring the option to refinance all or a
portion of its senior secured term loans originally entered into on
December 22, 2010.
While the year-end audit process is ongoing, ConvaTec presently
expects adjusted EBITDA for the year ended December 31, 2010 to be
within a range of approximately $425-435mm, although this view is
based on a number of assumptions and estimates. ConvaTec management
cautions that the foregoing information has not been audited or
reviewed by the company’s independent auditors and should not be
regarded as a representation or forecast by ConvaTec or any other
person affiliated with the company regarding the results that will
be reported for the year ended December 31, 2010.
About ConvaTecConvaTec is a leading developer and marketer of
innovative medical technologies. With four key focus areas –
Ostomy Care, Wound Therapeutics, Continence and Critical Care, and
Infusion Devices – ConvaTec products support healthcare
professionals from the hospital to the community health setting.
From its operational headquarters in Skillman, New Jersey, the
company conducts business in over 100 countries, serving consumers
and their health care professionals on six continents. For
more information, please visit www.convatec.com.
Certain statements in this press release are forward-looking
statements within the meaning of the Private Securities Litigation
Reform Act of 1995. Forward looking statements are all statements
other than statements of historical facts. Certain of these
forward looking statements are identified by terminology such as
“aim,” “anticipate,” “believe,” “continue,” “could,”